ArticleAddiction science & clinical practice2024

Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder.

Pouya Azar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.